2024-519107-10-00Not yet recruitingPhase 4
HeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 27 May 2025 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- First submitted
- 6 Dec 2024
- Start date
- 13 Jan 2025
- Lead sponsor
- Universita' Degli Studi Di Genova
- Diseases
- Amyloidosis
- EU CT number
- 2024-519107-10-00
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 104
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Azienda Ospedaliera Universitaria Careggi | Firenze | Italy | Not yet recruiting |
| Ircss Ospedale Policlinico San Martino | Genova | Italy | Not yet recruiting |
| Università Sapienza, Azienda Ospedaliera Sant’Andrea | Roma | Italy | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.